We present a novel method to analyze clenbuterol based on a competitive microfluidic immunoassay scheme with a micro-ELISA system, and obtain a limit of detection that is less than 0.1 ng ml−1 with a quantitative working range of 0.1 ng ml−1 to 27.0 ng ml−1. The approach was envisaged to be a promising method for efficient onsite clenbuterol control with good sensitivity and portability.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: